Nymox Pharmaceutical Corporation carries a market capitalization of 18.24M, placing it among publicly traded companies globally.
| Market Cap | 18.24M |
| Enterprise Value | N/A |
Nymox Pharmaceutical Corporation's stock has declined approximately -48.61183% over the past 52 weeks. The 50-day moving average sits at 0.39, while the 200-day moving average is 0.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | -48.61183% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.39 |
| Average Volume (20 Days) | N/A |